Rigel Pharmaceuticals, Inc. (RIGL)
34.92
-1.28
(-3.52%)
USD |
NASDAQ |
Feb 04, 16:00
34.57
-0.36
(-1.02%)
After-Hours: 20:00
Rigel Pharmaceuticals Market Cap : 633.93M for Feb. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 650.84M |
| Ironwood Pharmaceuticals, Inc. | 728.80M |
| BioMarin Pharmaceutical, Inc. | 11.07B |
| Catalyst Pharmaceuticals, Inc. | 3.080B |
| Perspective Therapeutics, Inc. | 379.12M |
Market Cap Related Metrics
| PE Ratio | 5.664 |
| PS Ratio | 2.274 |
| PEG Ratio | 0.0020 |
| Price to Book Value | 5.390 |
| Price to Free Cash Flow | 9.415 |
| Price | 34.92 |
| Earnings Yield | 17.66% |
| PEGY Ratio | 0.0020 |
| Operating PE Ratio | 5.393 |
| Normalized PE Ratio | 5.664 |